251 related articles for article (PubMed ID: 21612107)
1. [Sugammadex, a new drug for reversion of muscle relaxants].
Kvolik S; Ikić V; Jukić M
Lijec Vjesn; 2011; 133(3-4):106-10. PubMed ID: 21612107
[TBL] [Abstract][Full Text] [Related]
2. Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessment.
Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Hunter JM; Sculpher M; Woolacott N
Br J Anaesth; 2010 Nov; 105(5):568-75. PubMed ID: 20937718
[TBL] [Abstract][Full Text] [Related]
3. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J
Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular transmission: new concepts and agents.
de Boer HD
J Crit Care; 2009 Mar; 24(1):36-42. PubMed ID: 19272537
[TBL] [Abstract][Full Text] [Related]
5. Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia.
Donati F
Expert Opin Pharmacother; 2008 Jun; 9(8):1375-86. PubMed ID: 18473711
[TBL] [Abstract][Full Text] [Related]
6. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
[TBL] [Abstract][Full Text] [Related]
7. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' situation?
Bisschops MM; Holleman C; Huitink JM
Anaesthesia; 2010 Sep; 65(9):936-41. PubMed ID: 21198485
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade.
Schaller SJ; Lewald H
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1097-108. PubMed ID: 27463265
[TBL] [Abstract][Full Text] [Related]
9. Use of sugammadex in a 'can't intubate, can't ventilate' situation.
Curtis R; Lomax S; Patel B
Br J Anaesth; 2012 Apr; 108(4):612-4. PubMed ID: 22287458
[TBL] [Abstract][Full Text] [Related]
10. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacology of sugammadex.
Bom A; Hope F; Rutherford S; Thomson K
J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
[TBL] [Abstract][Full Text] [Related]
12. The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios.
Naguib M; Brewer L; LaPierre C; Kopman AF; Johnson KB
Anesth Analg; 2016 Jul; 123(1):82-92. PubMed ID: 27140684
[TBL] [Abstract][Full Text] [Related]
13. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
[TBL] [Abstract][Full Text] [Related]
14. [Sugammadex, a novel drug for neuromuscular blockade reversal].
Fernández Meré LA; Alvarez-Blanco M
Rev Esp Anestesiol Reanim; 2010 Feb; 57(2):95-102. PubMed ID: 20337001
[TBL] [Abstract][Full Text] [Related]
15. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
[TBL] [Abstract][Full Text] [Related]
16. Sugammadex: another milestone in clinical neuromuscular pharmacology.
Naguib M
Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
[TBL] [Abstract][Full Text] [Related]
17. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
[TBL] [Abstract][Full Text] [Related]
18. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report.
Kim JE; Chun HR
Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578
[TBL] [Abstract][Full Text] [Related]
19. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
de Boer HD; van Esmond J; Booij LH; Driessen JJ
Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics and effectiveness of sugammadex].
Otomo S; Sasakawa T; Kunisawa T; Iwasaki H
Masui; 2013 Jan; 62(1):27-37. PubMed ID: 23431891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
